Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b study

Abstract SAR439459 (SAR'459), a "second‐generation" human anti‐transforming growth factor beta (TGFβ) monoclonal antibody, enhances the activity of immune checkpoint inhibitors. In this phase I/Ib study, we evaluated the safety, pharmacokinetics (PK), pharmacodynamics, and antitumor a...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Joaquina C. Baranda (Autor), Debbie Robbrecht (Autor), Ryan Sullivan (Autor), Bernard Doger (Autor), Armando Santoro (Autor), Minal Barve (Autor), Jean‐Jacques Grob (Autor), Oliver Bechter (Autor), Maria Vieito (Autor), Maria Jose deMiguel (Autor), Dirk Schadendorf (Autor), Melissa Johnson (Autor), Clemence Pouzin (Autor), Cathy Cantalloube (Autor), Rui Wang (Autor), Jooyun Lee (Autor), Xiaofei Chen (Autor), Brigitte Demers (Autor), Amele Amrate (Autor), Giovanni Abbadessa (Autor), F. Stephen Hodi (Autor)
Format: Llibre
Publicat: Wiley, 2024-06-01T00:00:00Z.
Matèries:
Accés en línia:Connect to this object online.
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet

Connect to this object online.

3rd Floor Main Library

Detall dels fons de 3rd Floor Main Library
Signatura: A1234.567
Còpia 1 Disponible